Lincoln Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹187.28 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.60 per cent from ₹166.32 crore. This corresponds to a year-on-year *(YoY) growth of 11.36 per cent.
Operating Profit
Operating Profit stands at ₹24.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.38 per cent from ₹23.59 crore. This corresponds to a year-on-year *(YoY) decline of 6.96 per cent.
PBDT
PBDT stands at ₹20.38 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 46.98 per cent from ₹38.44 crore. This corresponds to a year-on-year *(YoY) growth of 4.62 per cent.
Profit Before Tax
Profit Before Tax stands at ₹16.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 51.90 per cent from ₹34.72 crore. This corresponds to a year-on-year *(YoY) growth of 2.77 per cent.
Net Profit
Net Profit stands at ₹11.63 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 59.34 per cent from ₹28.60 crore. This represents a 0.43 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Lincoln Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Lincoln Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Lincoln Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Lincoln Pharmaceuticals Ltd Financial Reports
Lincoln Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lincoln Pharma. | 1.35% | 0.62% | -2.74% | 7.17% | 27.76% | 12.76% |
| Shukra Pharma. | -0.03% | 4.24% | 14.95% | 6.20% | -26.10% | 66.02% |
| Fredun Pharma | -1.96% | 1.83% | 11.80% | 41.97% | 84.75% | 188.45% |
| Syncom Formul. | 1.21% | 1.36% | -0.77% | 6.06% | 7.91% | -25.45% |
| Fermenta Biotec. | 2.63% | 4.22% | 21.50% | 26.35% | 28.78% | 4.51% |
| Bajaj Healthcare | -0.51% | 3.97% | 15.01% | 4.59% | -9.39% | -32.17% |
| Themis Medicare | 0.00% | -3.31% | 12.23% | 42.35% | 23.03% | -6.70% |
Company Info
Company Information
Chairman & Non Executive Dir. : Kishorbhai M Shah
ED / MD / Promoter : Mahendra G Patel
WTD & Executive Director : Hasmukhbhai I Patel
WTD & Executive Director : Ashish Rajanikant Patel
WTD & Executive Director : Munjal Mahendrabhai Patel
Non-Exec & Non-Independent Dir : Rajnikant G Patel
Independent Non Exe. Director : Saurin Jagdish Bhai Parikh
Independent Non Exe. Director : Nareshkumar Pirabhai Suthar
Independent Non Exe. Director : Seema Mehta
Company Sec. & Compli. Officer : Trusha Shah